SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta shares are facing downward pressure as investors grapple with higher-than-anticipated capital expenditures on AI infrastructure and a significant decline in free cash flow, overshadowing the company's solid revenue growth. The community remains deeply divided, with some investors viewing the dip as a long-term buying opportunity in a dominant ad-revenue machine, while others express frustration over management's heavy spending and the persistent lack of clear, short-term returns on their massive AI investments.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following the UAE's broad approval of Anktiva for bladder and lung cancer, sparking optimism regarding global regulatory expansion and potential revenue growth. The community remains focused on upcoming quarterly earnings, speculation about international partnerships, and the heavy short interest surrounding the stock.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holdings is trending as investors rally behind a strong performance outlook, fueled by record-high commercial engine flying hours, successful strategic transformation initiatives, and growing momentum in the Small Modular Reactor (SMR) market. The community is actively discussing raised profit guidance, aggressive share buybacks, and potential contract wins in defense and aviation, with many long-term holders expressing optimism about the stock's growth trajectory and future mid-term results.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending as investors react to a strong quarterly earnings report that beat expectations, particularly highlighting robust Azure cloud growth and a commitment to maintaining stable capital expenditure. The stock is currently being viewed by the community as a market stabilizer, with many discussing a potential short squeeze as institutional confidence returns to the name.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors actively debate its valuation, potential robotic and AI growth, and the broader impact of recent leadership and geopolitical developments. The community remains heavily polarized, with many traders discussing aggressive put-positioning and key support levels around the three-hundred-dollar mark while others debate whether recent price action represents a buying opportunity or a deeper correction.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health shares are under significant pressure as the company reported a revenue miss and issued weaker-than-expected guidance, prompting concerns among the investor community regarding the BetterHelp segment's performance and execution. While some investors remain optimistic about the long-term potential of the integrated care platform and its expansion into insurance, others are actively debating the company's leadership and the sustainability of its business model amidst ongoing competition.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is seeing renewed investor interest and increased volume following the announcement of record-breaking ABS issuances and a strategic expansion of its AI credit-scoring platform into the buy-now-pay-later sector. While the community remains sharply divided over the impact of broader macro volatility and high short interest, bulls are focused on the companys consecutive quarters of profitability and recent insider share purchases as signals that the stock is undervalued.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuum ($QNT) is trending following its recent high-profile IPO, which has drawn intense attention from retail traders debating its valuation, market positioning, and long-term potential compared to peers like $IONQ and $INFQ. Community discussion is polarized, with some investors betting on its Honeywell backing and technological roadmap, while others remain skeptical of its high revenue multiples, lack of near-term profitability, and intense market volatility.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as bond market participants react to intensifying Middle East tensions and rising oil prices, which have revived inflation fears and pushed long-term Treasury yields toward recent highs. The community is actively debating whether current bond selloffs represent a final capitulation before a flight-to-quality rally or a sign of deeper structural instability that will necessitate further rate hikes.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant market volatility driven by high short interest and anticipation surrounding its upcoming earnings and merger vote. Community discussion focuses on the company's expanding enterprise footprintincluding a key integration with Deliverectand the perceived disconnect between this ongoing business growth and the stock's recent price performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline

Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TG Therapeutics (TGTX) to Report Q2 Results: Wall Street Expects Earnings Growth

TG Therapeutics (TGTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm Kuehn Law Encourages Investors of TG Therapeutics, Inc. to Contact Law Firm PR Newswire NEW YORK, July 21, 2026 NEW YORK, July 21, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating...

TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations

TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations...

TGTX Stock Rises On Wall Street Price Target Hike, New Schizophrenia Trial Launch

Equity

Bank of America analyst Alec Stranahan raised his price target on TG Therapeutics to $20 from $17 but kept an ‘Underperform’ rating on the shares.


TG Therapeutics Begins Phase II Study With Briumvi in Schizophrenia

TGTX initiates a phase II study evaluating Briumvi in adult patients with treatment-resistant schizophrenia. Shares rise.

Will Briumvi's Strength Continue to Aid TGTX's Top Line in Q2?

TG Therapeutics continues to witness rising Briumvi demand. Investors are closely watching the sales numbers of the drug.

Immunovant (IMVT) Up 3.6% Since Last Earnings Report: Can It Continue?

Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TG Therapeutics Stock Rises Thursday: What's Driving The Gains?

TG Therapeutics shares are trading higher on Thursday as traders keep leaning into recent upbeat clinical updates around BRIUMVI.read more...

TGTX Stock Continues Rally For 8 Straight Sessions On New BRIUMVI Clinical Data

Recent announcements from TG Therapeutics have buoyed optimism on the long-term potential of its Briumvi drug. 

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.

TG Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$53.48
Prev Close	$54.87
Open	$54.87
Dividend Yield	0.00%
50-Day Moving Average	$49.39
Beta	0.98
Avg. Volume	3.08M
PE Ratio	18.64

52-Week High	$59.30
52-Week Low	$25.28
Market Capitalization	$8.4B
EPS (Annual)	$2.77
Price to Book	14.04
Revenue Per Employee	$1.54M

Feed

News

Sentiment

Earnings

Fundamentals

Info

TGTXTG Therapeutics Inc

Latest TGTX News